Patricia A. Fraser

4.3k total citations · 1 hit paper
58 papers, 3.1k citations indexed

About

Patricia A. Fraser is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patricia A. Fraser has authored 58 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 30 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patricia A. Fraser's work include T-cell and B-cell Immunology (21 papers), Systemic Lupus Erythematosus Research (20 papers) and Immune Cell Function and Interaction (10 papers). Patricia A. Fraser is often cited by papers focused on T-cell and B-cell Immunology (21 papers), Systemic Lupus Erythematosus Research (20 papers) and Immune Cell Function and Interaction (10 papers). Patricia A. Fraser collaborates with scholars based in United States, United Kingdom and Canada. Patricia A. Fraser's co-authors include Michael E. Weinblatt, Donald E. Holdsworth, David E. Trentham, Jonathan S. Coblyn, David N. Glass, David A. Fox, Agnes L. Maier, Jonathan S. Coblyn, Kenneth R. Falchuk and Barbara N. Weissman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Patricia A. Fraser

58 papers receiving 2.9k citations

Hit Papers

Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis 1985 2026 1998 2012 1985 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
    1985 705 citations Michael E. Weinblatt, Jonathan S. Coblyn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia A. Fraser United States 27 1.7k 976 749 425 331 58 3.1k
Joseph A. Markenson United States 20 2.2k 1.3× 587 0.6× 1.0k 1.4× 414 1.0× 192 0.6× 42 3.0k
Johanna M. W. Hazes Netherlands 29 2.0k 1.2× 1.2k 1.2× 787 1.1× 288 0.7× 364 1.1× 81 3.6k
S. Louis Bridges United States 34 2.0k 1.2× 1.1k 1.1× 578 0.8× 534 1.3× 611 1.8× 138 3.9k
Robert F. Willkens United States 32 2.4k 1.4× 656 0.7× 811 1.1× 442 1.0× 164 0.5× 68 3.7k
Ennio Giulio Favalli Italy 34 2.2k 1.3× 915 0.9× 864 1.2× 455 1.1× 341 1.0× 138 3.5k
Chris Deighton United Kingdom 23 1.5k 0.9× 514 0.5× 419 0.6× 271 0.6× 172 0.5× 73 2.4k
Andrew J.K. Östör United Kingdom 31 1.9k 1.2× 982 1.0× 898 1.2× 345 0.8× 265 0.8× 131 3.8k
Burkhard F. Leeb Austria 27 3.4k 2.1× 1.1k 1.1× 1.0k 1.4× 471 1.1× 438 1.3× 76 5.2k
Markku Korpela Finland 34 2.7k 1.6× 679 0.7× 693 0.9× 349 0.8× 472 1.4× 86 4.0k
Elisa Gremese Italy 35 2.2k 1.3× 1.2k 1.3× 718 1.0× 306 0.7× 700 2.1× 243 4.2k

Countries citing papers authored by Patricia A. Fraser

Since Specialization
Citations

This map shows the geographic impact of Patricia A. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Fraser more than expected).

Fields of papers citing papers by Patricia A. Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Fraser. The network helps show where Patricia A. Fraser may publish in the future.

Co-authorship network of co-authors of Patricia A. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia A. Fraser. A scholar is included among the top collaborators of Patricia A. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia A. Fraser. Patricia A. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noel, Marcus Smith, Bhaskar Srivastava, Scott R. Daigle, et al.. (2024). Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update.. Journal of Clinical Oncology. 42(16_suppl). 3083–3083. 6 indexed citations
2.
Díaz, George A., Simon Jones, Maurizio Scarpa, et al.. (2021). One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency. Genetics in Medicine. 23(8). 1543–1550. 50 indexed citations
3.
Dimachkie, Mazen M., Richard J. Barohn, Priya S. Kishnani, et al.. (2019). NEO1 AND NEO-EXT STUDIES: PHARMACODYNAMIC/EXPLORATORY BIOMARKER AND SAFETY ASSESSMENTS FOLLOWING REPEAT AVALGLUCOSIDASE ALFA DOSING FOR UP TO 4.5 YEARS IN PATIENTS WITH LATE-ONSET POMPE DISEASE. 60. 1 indexed citations
4.
5.
Ruiz-Narváez, Edward, Patricia A. Fraser, Julie R. Palmer, et al.. (2011). MHC region and risk of systemic lupus erythematosus in African American women. Human Genetics. 130(6). 807–815. 20 indexed citations
6.
Karlson, Elizabeth W., Jing Cui, Lori B. Chibnik, et al.. (2009). Gene–environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(1). 54–60. 180 indexed citations
7.
Finckh, Axel, Glinda S. Cooper, Lori B. Chibnik, et al.. (2006). Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis & Rheumatism. 54(11). 3648–3654. 71 indexed citations
8.
Tian, Weidong, Deborah A. Boggs, Michael Mohseni, et al.. (2003). MICA, HLA-B haplotypic variation in five population groups of sub-Saharan African ancestry. Genes and Immunity. 4(7). 500–505. 30 indexed citations
9.
Jordan, Joanne M., Reva C. Lawrence, Raynard Kington, et al.. (2002). Ethnic health disparities in arthritis and musculoskeletal diseases: Report of a scientific conference. Arthritis & Rheumatism. 46(9). 2280–2286. 42 indexed citations
10.
Husni, M. Elaine, Agnes L. Maier, Philip J. Mease, et al.. (2002). Etanercept in the treatment of adult patients with Still's disease. Arthritis & Rheumatism. 46(5). 1171–1176. 136 indexed citations
11.
Weinblatt, Michael E., Agnes L. Maier, Patricia A. Fraser, & Jonathan S. Coblyn. (1998). Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.. PubMed. 25(2). 238–42. 99 indexed citations
12.
Wolf, Robert, et al.. (1998). Soluble HLA-I in rheumatic diseases. Human Immunology. 59(10). 644–649. 17 indexed citations
13.
14.
Fraser, Patricia A., et al.. (1996). ASSOCIATION OF SERUM CONCENTRATIONS OF SOLUBLE CLASS I HLA WITH HLA ALLOTYPES. Transplantation. 61(6). 984–987. 25 indexed citations
15.
Weinblatt, Michael E., David E. Trentham, Patricia A. Fraser, et al.. (1988). Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 31(2). 167–175. 192 indexed citations
16.
Fraser, Patricia A., et al.. (1988). The timing of menarche in juvenile rheumatoid arthritis. Journal of Adolescent Health Care. 9(6). 483–487. 21 indexed citations
17.
Turka, Laurence A., et al.. (1987). Antigen specificity of mixed lymphocyte response-induced suppressor cells. Human Immunology. 20(4). 293–306. 8 indexed citations
18.
Fox, David A., James D. Faix, Jonathan S. Coblyn, et al.. (1986). Thrombotic thrombocytopenic purpura and systemic lupus erythematosus.. Annals of the Rheumatic Diseases. 45(4). 319–322. 26 indexed citations
19.
Miller, Marc L., Stephen Aaron, Patricia A. Fraser, et al.. (1985). HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis & Rheumatism. 28(2). 146–150. 40 indexed citations
20.
Fraser, Patricia A., et al.. (1983). The pattern of disease in hospital, 1968-1978.. PubMed. 15(1). 1–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. Markenson Breakdown of academic impact, for papers by Johanna M. W. Hazes Breakdown of academic impact, for papers by S. Louis Bridges Breakdown of academic impact, for papers by Robert F. Willkens Breakdown of academic impact, for papers by Ennio Giulio Favalli Breakdown of academic impact, for papers by Chris Deighton Breakdown of academic impact, for papers by Andrew J.K. Östör Breakdown of academic impact, for papers by Burkhard F. Leeb Breakdown of academic impact, for papers by Markku Korpela Breakdown of academic impact, for papers by Elisa Gremese
Rankless by CCL
2026